Definitive Healthcare (NASDAQ:DH) Now Covered by Analysts at BTIG Research

BTIG Research assumed coverage on shares of Definitive Healthcare (NASDAQ:DH) in a research report report published on Tuesday morning, MarketBeat.com reports. The firm issued a buy rating and a $7.00 price objective on the stock.

Several other research analysts have also commented on DH. Deutsche Bank Aktiengesellschaft reduced their price target on Definitive Healthcare from $7.00 to $5.00 and set a hold rating for the company in a research report on Friday, August 9th. Morgan Stanley reduced their target price on shares of Definitive Healthcare from $9.00 to $5.00 and set an equal weight rating for the company in a report on Tuesday, August 6th. Needham & Company LLC restated a hold rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. Barclays reduced their price objective on shares of Definitive Healthcare from $6.00 to $4.00 and set an equal weight rating for the company in a research note on Wednesday, August 7th. Finally, JPMorgan Chase & Co. downgraded shares of Definitive Healthcare from a neutral rating to an underweight rating and lowered their target price for the company from $7.00 to $5.00 in a research note on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Definitive Healthcare currently has a consensus rating of Hold and a consensus price target of $5.81.

Definitive Healthcare Stock Performance

DH stock opened at $4.81 on Tuesday. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62. The business has a 50-day moving average price of $4.63 and a 200 day moving average price of $5.90. The company has a market capitalization of $567.27 million, a P/E ratio of -2.75, a PEG ratio of 6.38 and a beta of 1.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, hitting the consensus estimate of $0.09. The firm had revenue of $63.70 million during the quarter, compared to analysts’ expectations of $63.19 million. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.08 EPS. As a group, equities research analysts forecast that Definitive Healthcare will post 0.07 EPS for the current fiscal year.

Hedge Funds Weigh In On Definitive Healthcare

Several hedge funds have recently made changes to their positions in DH. Swiss National Bank increased its holdings in Definitive Healthcare by 2.9% in the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after buying an additional 2,900 shares during the period. The Manufacturers Life Insurance Company increased its stake in shares of Definitive Healthcare by 17.0% in the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after acquiring an additional 3,332 shares during the period. Principal Financial Group Inc. lifted its position in Definitive Healthcare by 10.8% during the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock valued at $218,000 after purchasing an additional 3,874 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after purchasing an additional 5,083 shares during the period. Finally, Valeo Financial Advisors LLC boosted its holdings in Definitive Healthcare by 11.8% in the second quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company’s stock valued at $323,000 after purchasing an additional 6,230 shares during the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.